
Drug behavior & delivery
Intravenous
Also found as: IV · intravenously · intravenous infusion
Administered into a vein. The BPC-157 pharmacokinetic paper abbreviates this route as IV.[1]
Source check: 2026-10-04 · Editorial method
How the research uses this term
Intravenous administration is the comparison route used when the researchers calculate absolute bioavailability after intramuscular administration.[1]
Reading the evidence
The phase I thymosin β4 study also used intravenous administration, but studied a different peptide preparation in healthy volunteers. Its safety observations belong to that preparation and study setting.[2]
Used in our guides
Continue reading where this term appears.
- BPC-157Read the term in context
- IpamorelinRead the term in context
- CJC-1295 + ipamorelinRead the term in context
References
Definitions and explanations are paraphrased. The source locations below identify the supporting passages and methods.
- Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogsPrimary research · Rats, dogs and laboratory samples · 2022DOI: 10.3389/fphar.2022.1026182
Source locations: Abstract and Methods; Tables 2 and 5 footnotes.
Review status · PendingSource packet file
Pharmacokinetics_of_body_protective_compound_157_nopmid_nopmc.pdf
- A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteersPrimary research · Human phase I trial · 2021DOI: 10.1111/jcmm.16693
Source locations: Trial design and Procedure.
Review status · PendingSource packet file
A_first_in_human_randomized_double_blind_single_and_multiple_dose_phase_34346165_PMC8419156.pdf